Ad is loading...
FIUIX
Price
$34.89
Change
+$0.46 (+1.34%)
Updated
Nov 15 closing price
FRURX
Price
$24.80
Change
+$0.38 (+1.56%)
Updated
Nov 15 closing price
Ad is loading...

FIUIX vs FRURX

Header iconFIUIX vs FRURX Comparison
Open Charts FIUIX vs FRURXBanner chart's image
Fidelity Telecom and Utilities
Price$34.89
Change+$0.46 (+1.34%)
VolumeN/A
CapitalizationN/A
Franklin Utilities R
Price$24.80
Change+$0.38 (+1.56%)
VolumeN/A
CapitalizationN/A
FIUIX vs FRURX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FIUIX vs. FRURX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIUIX is a Buy and FRURX is a Buy.

FUNDAMENTALS
Fundamentals
FRURX has more cash in the bank: 6.73B vs. FIUIX (1.17B). FRURX (2.10) and FIUIX (2.04) have matching dividends . FIUIX was incepted earlier than FRURX: FIUIX (37 years) vs FRURX (23 years). FIUIX is a more actively managed with annual turnover of: 64.00 vs. FRURX (4.43). FIUIX has a lower initial minimum investment than FRURX: FIUIX (0) vs FRURX (1000). FIUIX annual gain was more profitable for investors over the last year : 33.57 vs. FRURX (30.47). FIUIX return over 5 years is better than : 34.82 vs. FRURX (22.76).
FIUIXFRURXFIUIX / FRURX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence37 years23 years-
Gain YTD31.21531.182100%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.17B6.73B17%
Annual Yield % from dividends2.042.1097%
Returns for 1 year33.5730.47110%
Returns for 3 years33.2822.33149%
Returns for 5 years34.8222.76153%
Returns for 10 years58.9953.02111%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GWRE192.22-3.04
-1.56%
Guidewire Software
BGSF5.99-0.25
-4.01%
BGSF
PTPI0.26-0.01
-4.18%
Petros Pharmaceuticals
KROS56.62-3.73
-6.18%
Keros Therapeutics
EB3.50-0.26
-6.91%
Eventbrite